ScreenerHero

CLNNClene Inc.

NAS · US · Healthcare · Packaged Foods · clene.com
4.320USD+3.10%Mkt Cap: 55.51M $P/E: —

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, w…

Industry Peers

Packaged Foods
Screen all
BN
Danone S.A.
$46.43BUSDP/E 22.0
JBS
JBS N.V. Class A Common Shares
$45.46BUSDP/E 12.9
KHC
Kraft Heinz Company
$30.33BUSD
GIS
General Mills, Inc.
$21.37BUSD
ABF
Associated British Foods plc
$18.21BUSDP/E 15.3
KRZ
Kerry Group plc
$14.51BUSDP/E 21.4
KYGA
Kerry Group plc
$13.96BUSDP/E 20.6
MKC-V
McCormick & Company, Incorporated
$14.96BUSDP/E 9.3
MKC
McCormick & Company, Incorporated
$14.90BUSDP/E 9.2
SJM
J.M. Smucker Company
$13.29BUSD
HRL
Hormel Foods Corporation
$13.14BUSDP/E 28.1
MICC
The Magnum Ice Cream Company N.V. Ordinary Shares
$12.22BUSDP/E 58.7
LOTB
Lotus Bakeries NV
$11.33BUSDP/E 54.7
MICC
THE MAGNUM ICE CREAM COMPANY N.
$11.30BUSDP/E 56.6
SAP
Saputo Inc.
$11.93BUSDP/E 23.7
DAR
Darling Ingredients Inc.
$10.37BUSDP/E 17.7
ORK
Orkla ASA
$8.77BUSDP/E 14.8
SFD
Smithfield Foods Inc. Common Stock
$8.76BUSDP/E 8.3
CAG
Conagra Brands, Inc.
$7.86BUSD
PPC
Pilgrim's Pride Corporation
$7.68BUSDP/E 14.1

Key Statistics

Company
Market Cap55.51M $
Enterprise Value69.01M $
Revenue (TTM)134.00K $
Gross Profit157.00K $
Net Income (TTM)-26.17M $
Revenue/Share0.0130 USD
Last Price4.320 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees76
CountryUS
SectorHealthcare
IndustryPackaged Foods
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.79
PEG—
EV/EBITDA-3.52
EV/Revenue515.01
P/S419.01
P/B-2.70
EPS (TTM)-3.65
EPS (Forward)-2.44
52W Range
3.6407% of range13.50
52W High13.50 USD
52W Low3.640 USD
Profitability
Gross Margin78.50%
Oper. Margin-13740.00%
EBITDA Margin0.00%
Profit Margin-13086.50%
ROE148.78%
ROA-144.35%
Growth
Revenue Growth-81.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.55M $
CapEx (TTM)39.00K $
FCF Margin-8638.90%
FCF Yield-20.86%
Net Debt16.11M $
Net Debt/EBITDA-0.82
Balance Sheet
Debt/Equity-1.23
Current Ratio1.94
Quick Ratio1.40
Book Value/Sh-1.6210 USD
Cash/Share0.4650 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJul 11, 2024
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)32.20 USD
Upside (mean)+645.4%
Target Range20.00 USD – 50.00 USD
$20.00+645.4% to mean$50.00
# Analysts5
Ownership
Shares Out.12.85M
Float9.69M
Insiders17.06%
Institutions31.55%
Short Interest
Short Ratio15.8d
Short % Float9.92%
Short % Out.7.42%
Shares Short947.55K
Short (prev mo.)988.91K
Technical
SMA 505.482 (-21.2%)
SMA 2006.084 (-29.0%)
Beta0.97
S&P 52W Chg18.16%
Avg Vol (30d)75.39K
Avg Vol (10d)111.88K
Technical Indicators
RSI (14)34.3
MACD-0.4112
MACD Signal-0.3519
MACD Hist.-0.0593
BB Upper5.904 USD
BB Middle4.860 USD
BB Lower3.816 USD
BB Width42.97%
ATR (14)0.3722 USD
Vol Ratio (20d)0.35x